HCA Healthcare, Inc. Financials

Market Capitalization $82.41 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	14.62
Forward PE	13.25
Price to Sales TTM	$1.18
Price to Book MRQ	$101.38
Enterprise to Revenue	1.83
Enterprise to EBITDA	9.26

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	8.52%
Operating Margin	13.78%
Return on Assets TTM	11.51%
Return on Equity TTM	1195.45%

Income Statement

Revenue TTM	$69,620,998,144
Revenue per Share TTM	$265.37
Quarterly Revenue Growth	7.90%
Gross Profit TTM	$28,252,000,256
EBITDA	$13,788,000,000
Net Income to Common TTM	$5,928,999,936
Diluted EPS TTM	$22.25
Quarterly Earnings Growth YoY	17.70%

Balance Sheet

Total Cash MRQ	$2,983,000,064
Total Cash per Share MRQ	$11.78
Total Debt MRQ	$
Total Debt to Equity MRQ	5711.07
Current Ratio MRQ	1.12
Book Value per Share MRQ	$-8.57

Cash Flow

Operating Cash Flow TTM	$10,629,000,192
Levered Free Cash Flow TTM	$4,146,749,952

HCA Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	253,296,992
Float Shares	180,486,849
Avg 10 Volume	1,722,240
Avg 30 Volume	None
Shares Short	4,401,009
Short Ratio	3.36
Short % of Shares	2.41%
% Held by Insiders	28.42%
% Held by Institutions	63.79%

Stock Price Summary

Beta	1.69
Fifty Two Week Low	$281.61
Fifty Two Week High	$417.14
Fifty Two Week Change	8.41%
Day 50 MA	$318.21
Day 200 MA	$344.70

Dividends and Splits

Forward Annual Dividend Rate	$2.64
Forward Annual Dividend Yield	0.84%
Trailing Annual Dividend Rate	$2.64
Trailing Annual Dividend Yield	0.84%
Payout Ratio	11.59%
Dividend Date	2024-12-27
Ex Dividend Date	2024-12-13
Last Split Factor
Last Split Date